Cargando…
I(f) current channel inhibitor (ivabradine) deserves cardioprotective effect via down-regulating the expression of matrix metalloproteinase (MMP)-2 and attenuating apoptosis in diabetic mice
BACKGROUND: Ivabradine (IVBD), a novel I(f)-channel inhibitor and specific heart rate-lowering agent, is known to have anti-oxidative activity that promotes endothelial function. However, the molecular mechanism through which IVBD acts on cardiac function has yet to be elucidated, especially in expe...
Autores principales: | Chen, Shao-Liang, Hu, Zuo-Ying, Zuo, Guang-Feng, Li, Ming-Hui, Li, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230832/ https://www.ncbi.nlm.nih.gov/pubmed/25361902 http://dx.doi.org/10.1186/1471-2261-14-150 |
Ejemplares similares
-
Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection
por: Bencsik, Péter, et al.
Publicado: (2018) -
Cardioprotective Effect of Novel Matrix Metalloproteinase Inhibitors
por: Gömöri, Kamilla, et al.
Publicado: (2020) -
Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
por: Hur, J. H., et al.
Publicado: (2000) -
Expression and function of matrix metalloproteinase (MMP)-28
por: Rodgers, Ursula R., et al.
Publicado: (2009) -
Quantification of matrix metalloproteinases MMP-8 and MMP-9 in gingival overgrowth
por: Orozco-Páez, Jennifer, et al.
Publicado: (2021)